[HTML][HTML] Trends and disparities in the use of neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma
JJ Duplisea, RJ Mason, CA Reichard, R Li… - Canadian Urological …, 2019 - ncbi.nlm.nih.gov
Methods We identified patients in the National Cancer Database who underwent radical or
partial cystectomy for cT2–cT4N0M0 urothelial carcinoma from 2006–2014. The proportion …
partial cystectomy for cT2–cT4N0M0 urothelial carcinoma from 2006–2014. The proportion …
Trends and disparities in the use of neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma
JJ Duplisea, RJ Mason… - Journal of the …, 2019 - mdanderson.elsevierpure.com
Introduction: Neoadjuvant chemotherapy (NAC) prior to radical or partial cystectomy is
considered the standard of care for eligible patients with muscle-invasive urothelial …
considered the standard of care for eligible patients with muscle-invasive urothelial …
Trends and disparities in the use of neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma
JJ Duplisea, RJ Mason, CA Reichard… - … = Journal de l' …, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction Neoadjuvant chemotherapy (NAC) prior to radical or partial cystectomy is
considered the standard of care for eligible patients with muscle-invasive urothelial …
considered the standard of care for eligible patients with muscle-invasive urothelial …
Trends and disparities in the use of neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma.
JJ Duplisea, RJ Mason, CA Reichard, R Li… - … Journal= Journal de …, 2018 - europepmc.org
Methods We identified patients in the National Cancer Database who underwent radical or
partial cystectomy for cT2-cT4N0M0 urothelial carcinoma from 2006-2014. The proportion of …
partial cystectomy for cT2-cT4N0M0 urothelial carcinoma from 2006-2014. The proportion of …
Trends and disparities in the use of neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma
JJ Duplisea, RJ Mason, CA Reichard, R Li… - Canadian Urological …, 2019 - cuaj.ca
Introduction: Neoadjuvant chemotherapy (NAC) prior to radical or partial cystectomy is
considered the standard of care for eligible patients with muscle-invasive urothelial …
considered the standard of care for eligible patients with muscle-invasive urothelial …
Trends and disparities in the use of neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma.
JJ Duplisea, RJ Mason, CA Reichard… - Canadian …, 2019 - search.ebscohost.com
Introduction: Neoadjuvant chemotherapy (NAC) prior to radical or partial cystectomy is
considered the standard of care for eligible patients with muscle-invasive urothelial …
considered the standard of care for eligible patients with muscle-invasive urothelial …
[PDF][PDF] Trends and disparities in the use of neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma
JJ Duplisea, RJ Mason, CA Reichard, R Li, Y Shen… - CUAJ, 2019 - cuaj.ca
Introduction: Neoadjuvant chemotherapy (NAC) prior to radical or partial cystectomy is
considered the standard of care for eligible patients with muscle-invasive urothelial …
considered the standard of care for eligible patients with muscle-invasive urothelial …